Erucic acid

CAS : 112-86-7

Ref. 3D-FE61461

Informations sur le produit

• Nom: Erucic acid
• Synonymes: (13Z)-13-Docosenoic acid, (13Z)-Docosenoic acid, (Z)-13-Docosenoic acid, (Z)-Docos-13-ensaure, (Z)-Erucic acid, (Z)-docos-13-enoic acid, 13(Z)-Docosenoic acid, 13-Docosenoic acid, (13Z)-, 13-Docosenoic acid, (Z)-, 13-cis-Docosenoic acid, Acide (Z)-docos-13-enoique, Erucicacid, Hystrene 2290, Jaric 22:1, Nouracid RE 07, Prifrac 2990, acido (Z)-docos-13-enoico, cis-13-Docosenoic acid, cis-13-Erucic acid, Δ13-cis-Docosenoic acid, Δ¹³-cis-Docosenoic acid

Description

Erucic acid is a model system for studying the effects of inhibitor molecules on nuclear DNA. It has been shown to inhibit the pathogenic mechanism of human cells by blocking the toll-like receptor signaling pathway. Erucic acid has also been shown to be an important factor in the matrix effect, which leads to oxidative injury in cardiac cells and is responsible for changes in energy metabolism. Erucic acid has also been used as a biocompatible polymer that can be used as an alternative to silicone in medical devices. This polymer has been shown to have glucose injection properties, which can lower blood sugar levels, and enzyme activities, which are important for many metabolic reactions. The molecular docking analysis of erucic acid and its binding with proteins may lead to new therapeutic drugs.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 338.57 g/mol
• Formule: C₂₂H₄₂O₂
• Degré de pureté: Min. 95%
• Couleur/Forme: White To Light (Or Pale) Yellow Solid Or Liquid (May Vary)
• InChI: InChI=1S/C22H42O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-22(23)24/h9-10H,2-8,11-21H2,1H3,(H,23,24)/b10-9-
• Code InChI: InChIKey=DPUOLQHDNGRHBS-KTKRTIGZSA-N
• SMILES: CCCCCCCC/C=C\CCCCCCCCCCCC(=O)O